Is it time to re-evaluate the routines about stopping/keeping platelet inhibitors in conjunction to ambulatory surgery?

Current Opinion in Anaesthesiology

Volumn 23, Issue 6, 2010, Pages 691-696

  Servin, Frederique S ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

antiplatelet drugs; aspirin; clopidogrel; outpatient; perioperative care

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOOXYGENASE 1; CYTOCHROME P450; DRUG METABOLITE; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOPROTEIN; PRASUGREL; PROTON PUMP INHIBITOR; PURINERGIC P2Y12 RECEPTOR; THROMBOXANE A2; TICAGRELOR;

ACUTE CORONARY SYNDROME; AMBULATORY SURGERY; ARTERY DISEASE; ARTIFICIAL HEART PACEMAKER; BARE METAL STENT; BINDING SITE; BLEEDING; CARDIOVASCULAR RISK; CATARACT EXTRACTION; CLINICAL EVALUATION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DENTAL SURGERY; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG ELUTING STENT; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SCREENING; DRUG TRANSFORMATION; ENDOSCOPIC ECHOGRAPHY; EXCISION; GASTROINTESTINAL ENDOSCOPY; GENETIC POLYMORPHISM; GOLD STANDARD; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LIGHT TRANSMISSION AGGREGOMETRY; LIVER METABOLISM; LOADING DRUG DOSE; MEASUREMENT; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE COMPLICATION; PERIPHERAL VASCULAR DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROTEIN PHOSPHORYLATION; RELIABILITY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SECONDARY PREVENTION; SKIN DEFECT; SKIN SURGERY; STROKE; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY PLATELET MAPPING ASSAY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; URINARY EXCRETION; UROLOGIC SURGERY; VALIDITY;

AMBULATORY SURGICAL PROCEDURES; ANESTHESIA; BLOOD LOSS, SURGICAL; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; HUMANS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS;

EID: 78649483132     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283402aa7     Document Type: Review

References (29)

1. Mollmann H, Nef HM, Hamm CW. Clinical pharmacology: Antiplatelet therapy during surgery. Heart 2010; 96:986-991. This review very clearly updates our knowledge of antiplatelet therapy in the surgical setting and synthesizes up-to-date guidelines.
2. Vicenzi MN, Meislitzer T, Heitzinger B, et al. Coronary artery stenting and noncardiac surgery: A prospective outcome study. Br J Anaesth 2006; 96:686-693.
3. Serebruany V, Shalito I, Kopyleva O. Prasugrel development: Claims and achievements. Thromb Haemost 2009; 101:14-22.
4. Mousa SA, Jeske WP, Fareed J. Antiplatelet therapy prasugrel: A novel platelet ADP P2Y12 receptor antagonist. Clin Appl Thromb Hemost 2010; 16:170-176.
5. James S, Akerblom A, Cannon CP, et al. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J 2009; 157:599-605.
6. Bal Dit Sollier C, Berge N, Boval B, et al. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel. Thromb Haemost 2010; 104:571-581. This is a comparison of various tests to monitor platelet function.
7. Metzler H, Pruller F, Munch A, et al. Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: A preliminary study on the role of P2Y12 receptor monitoring. Eur J Anaesthesiol 2010; 27:138-145.
8. PriceMJ. Bedside evaluation of thienopyridine antiplatelet therapy. Circulation 2009; 119:2625-2632.
9. Collyer TC, Gray DJ, Sandhu R, et al. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thromboelastography Platelet Mapping. Br J Anaesth 2009; 102:492-498.
10. Kaur J, Jones N, Mallett S. Thromboelastography Platelet Mapping is a useful preoperative tool in surgical patients taking antiplatelet medication. Br J Anaesth 2009; 103:304; author reply 305.
11. Angiolillo DJ. Variability in responsiveness to oral antiplatelet therapy. Am J Cardiol 2009; 103:27A-34A.
12. Collet JP, Hulot JS, Pena A, et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: A cohort study. Lancet 2009; 373:309-317. Variability of clopidogrel efficacy due to genetic polymorphism has significant clinical consequences.
13. Simon T, Verstuyft C, Mary-Krause M, et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009; 360:363-375.
14. Momary KM, Dorsch MP. Factors associated with clopidogrel nonresponsiveness. Future Cardiol 2010; 6:195-210.
15. Merkely B, Toth-Zsamboki E, Becker D, et al. Very late drug-eluting stent thrombosis after nonsteroidal anti-inflammatory drug treatment despite dual antiplatelet therapy. Can J Cardiol 2009; 25:229-232. This is a case report that addresses the problem of drug interaction with a common pain killer.
16. Tompkins C, Cheng A, Dalal D, et al. Dual antiplatelet therapy and heparin 'bridging' significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 2010; 55:2376-2382.
17. Anwaruddin S, Askari AT, Saudye H, et al. Characterization of postoperative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv 2009; 2:542-549.
18. Eberli D, Chassot PG, Sulser T, et al. Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol 2010; 183:2128-2136. A very good analysis of the literature on APD in the surgical environment, written by anesthesiologists
19. Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery. Heart Lung Circ 2010; 19:2-10 This is an excellent review with clear recommendations.
20. Veitch AM, Baglin TP, Gershlick AH, et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008; 57:1322-1329.
21. Kwok A, Faigel DO. Management of anticoagulation before and after gastrointestinal endoscopy. Am J Gastroenterol 2009; 104:3085-3097.
22. Dixon AJ, Dixon MP, Dixon JB. Bleeding complications in skin cancer surgery are associated with warfarin but not aspirin therapy. Br J Surg 2007; 94:1356-1360.
23. Kramer E, Hadad E, Westreich M, Shalom A. Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls. Am Surg 2010; 76:11-14. A clinical study that may have a direct practical impact in the ambulatory setting.
24. Napenas JJ, Hong CH, Brennan MT, et al. The frequency of bleeding complications after invasive dental treatment in patients receiving single and dual antiplatelet therapy. J Am Dent Assoc 2009; 140:690-695.
25. Morimoto Y, Niwa H, Minematsu K. Hemostatic management for periodontal treatments in patients on oral antithrombotic therapy: A retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108:889-896.
26. Van Diermen DE, Aartman IH, Baart JA, et al. Dental management of patients using antithrombotic drugs: Critical appraisal of existing guidelines. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107:616-624.
27. Giannarini G, Mogorovich A, Valent F, et al. Continuing or discontinuing lowdose aspirin before transrectal prostate biopsy: Results of a prospective randomized trial. Urology 2007; 70:501-505.
28. Ehrlich Y, Yossepowitch O, Margel D, et al. Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: A prospective, randomized trial. J Urol 2007; 178:524-528.
29. Kutinsky IB, Jarandilla R, Jewett M, Haines DE. The risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 2010; 3:312-318.